Deals Of The Week: Johnson & Johnson/Synthes, Kadmon/Nano Terra, Lilly/Medtronic
Executive Summary
Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at http://invivoblog.blogspot.com.
You may also be interested in...
A Busy Month: Russia Looks To Localization, Technology Transfer To Spur Innovation (Part 1 of 2)
It’s only 2012, but Russia’s Pharma 2020 program hit new highs last month with novel deals from Abbott, J&J, Merck and Pfizer.
Russia's First BioPharma Public-Private Partnership Eyes Bio-Betters, Attracts $110 Million
Russia's bid to catch up in the global race to establish a recognized biopharma sector picked up speed with the Aug. 4 announcement of SynBio, a $110 million joint venture to develop bio-betters and innovative medicines for the Russian and international markets
Russia's First BioPharma Public-Private Partnership Eyes Bio-Betters, Attracts $110 million
Russia's bid to catch up in the global race to establish a recognized biopharma sector picked up speed with the Aug. 4 announcement of SynBio, a $110 million joint venture to develop bio-betters and innovative medicines for the Russian and international markets.